Recent Articles
Splunk Stock Faces Short-Term Pain but Long-Term Gain
Splunk has long-term growth as the data revolution continues to explode. However, short-term obstacles linger. Let's size up SPLK stock.
Find Out What Took Place During our Exclusive Research Meeting
It shouldn’t surprise you that I’m a big fan of the show Billions on Showtime. If you are, too, you might remember a scene from the first episode of Season 3 in which there’s a meeting in a private dining room of a New York City high-end restaurant called Del Posto. The gathering was an “idea meeting” with some of the biggest players in the hedge fund world. In the screenshot below, you can see Taylor (one of the smart people in the series) standing up to pitch their next big idea. Here at InvestorPlace, we have similar meetings between analysts, editors, and research teams on a fairly regular basis. Pre-COVID they were in person… typically in a conference room in the office.
Must-Watch Support for Canopy Growth Stock
Canopy Growth beat on earnings and revenue expectations, but CGC stock is having trouble rallying. Here's how to look at the stock now.
Buy the Dips in Lemonade Stock Despite Earnings Selloff
Lemonade beat on Q2 expectations, but came up just short of Q3 expectations. Let's look to buy the dip in LMND stock as a result.
Ocugen Investors Are Missing the Obvious Signs of Failure
Initially, the stupendous rise of OCGN stock may give you the case of the FOMOs. But don’t let that emotions guide you as Ocugen is driven by completely irrational actors.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
